We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
Turnover
20%
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
-13.18%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$518M
AUM Growth
-$189M
(-27%)
Cap. Flow
-$68.4M
Cap. Flow
% of AUM
-13.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
3
Closed
–
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.8
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$29M |
| 2 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
+$25.8M |
| 3 |
Repare Therapeutics
RPTX
|
+$13.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM
MPM Asset Management's Q1 2021 Portfolio in Review
As of Q1 2021, MPM Asset Management held 8 positions worth $518M, down 27% from $707M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MPM Asset Management withdrew a net $68.4M in Q1 2021, reducing 3 holdings. Its largest reduction was Rhythm Pharmaceuticals, cutting an estimated $29M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- MPM Asset Management's biggest Q1 2021 reduction was Rhythm Pharmaceuticals, cutting an estimated $29M.
- MPM Asset Management's ten largest holdings make up 100% of its $518M portfolio in Q1 2021.
- MPM Asset Management opened 0 new positions and closed 0 in Q1 2021.
- MPM Asset Management's portfolio value fell 27% quarter-over-quarter to $518M.
Based on MPM Asset Management's 13F filing for Q1 2021, filed 13 May 2021.